Viking Therapeutics Inc [VKTX] stock prices are down -2.47% to $57.18 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The VKTX shares have gain 11.53% over the last week, with a monthly amount glided 8.44%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Viking Therapeutics Inc [NASDAQ: VKTX] stock has seen the most recent analyst activity on June 27, 2024, when Morgan Stanley initiated its Overweight rating and assigned the stock a price target of $105. Previously, Raymond James upgraded its rating to Strong Buy on May 16, 2024, and elevated its price target to $116. On March 26, 2024, Oppenheimer reiterated its Outperform rating and revised its price target to $138 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $110 on March 07, 2024. Oppenheimer reiterated its recommendation of a Outperform and raised its price target to $116 on February 28, 2024. In a note dated March 28, 2023, Maxim Group reiterated an Buy rating on this stock and boosted its target price from $15 to $25.
The stock price of Viking Therapeutics Inc [VKTX] has been fluctuating between $8.28 and $99.41 over the past year. Currently, Wall Street analysts expect the stock to reach $100.5 within the next 12 months. Viking Therapeutics Inc [NASDAQ: VKTX] shares were valued at $57.18 at the most recent close of the market. An investor can expect a potential return of 75.76% based on the average VKTX price forecast.
Analyzing the VKTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -262.3%, Pretax Profit Margin comes in at -214.95%, and Net Profit Margin reading is -214.95%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.18 and Total Capital is -0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 56.28 points at the first support level, and at 55.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 58.94, and for the 2nd resistance point, it is at 60.69.
Ratios To Look Out For
It’s worth pointing out that Viking Therapeutics Inc [NASDAQ:VKTX]’s Current Ratio is 29.48. On the other hand, the Quick Ratio is 29.48, and the Cash Ratio is 5.97.
Transactions by insiders
Recent insider trading involved ZANTE GREG, Chief Financial Officer, that happened on May 03 ’24 when 66756.0 shares were sold. Chief Operating Officer, Mancini Marianna completed a deal on May 01 ’24 to sell 0.28 million shares. Meanwhile, President & CEO Lian Brian sold 45000.0 shares on Feb 09 ’24.
